AARD 8-K 2026-01-12

Aardvark Therapeutics, Inc. (AARD) 8-K dated 2026-01-12 — accession 0001193125-26-009862. This URL is the filing, not the AARD hub.

Aardvark Therapeutics, Inc. (AARD) is a biotechnology company listed on US.

Aardvark Therapeutics, Inc. filed a 8-K on 2026-01-12. Accession 0001193125-26-009862.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.

Not investment advice. The AARD SEC hub lists recent forms. The stock page is the research view.